.jpg?width=2000&name=20230424_Siegfried_Barcelona18803_300ppi_RGB_RZ%20(1).jpg)
Maximizing speed to clinical from the start
Your comprehensive partner for early-phase drug development and manufacturing. This includes phase appropriate development of analytical and validation method as well as comprehensive expertise in chromatography.
Providing services from preclinical through commercial, including scale-up, tech transfer, validation and launch. 24 DMFs throughout the US, Canada, Japan and the EU.
Offering services for highly potent molecules with an OEL of <0.1 mg/m3. 6 DEA registrations (both international and domestic) from research through manufacturing at all levels of controlled substances from CI-CV.
Based in the US, the Siegfried Acceleration Hub offers you early-phase development and manufacturing services, enabling rapid speed to clinical. We offer phase-appropriate analytical and development services, regulatory expertise, and regulatory-compliant quality systems — all with the capability to manage highly potent and controlled APIs — positioning us as your trusted partner in early-phase drug development and manufacturing.
An agile team with extensive experience in accelerating drug development through early phases, backed by Siegfried's 150 years of development expertise.
Regulatory compliance, transparency, and faster development by eliminating offshore transfer risks. Physical proximity enables real-time collaboration, reducing delays and ensuring efficient, sustainable scale-up.
Seamless transfer into Siegfried's global network, from early-phase to commercial manufacturing. All from a single supplier.
Subscribe now to get more expert insights
Contact us for more information about the Siegfried Acceleration Hub and its offerings